Carol S. Lim
Molecular Biology · 2013–2014
A researcher in the Science corpus: 2 papers; trusts 3 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 36 citations into it
Whom Carol S. Lim trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from Carol S. Lim's perspective
Ordered by how strongly the researchers Carol S. Lim trusts endorse each paper. Same corpus, a different order for every researcher.
- Synthetic therapeutic peptides: science and market. (Drug Discovery Today)
- Carbon nanotubes as intracellular protein transporters: generality and biological functionality. (Journal of the American Chemical Society)
- Mechanisms of Cellular Uptake of Cell-Penetrating Peptides (Journal of Biophysics)
- Hippo pathway effector Yap promotes cardiac regeneration (Proceedings of the National Academy of Sciences of the United States of America)
- KRAS and YAP1 converge to regulate EMT and tumor survival (Cell)
- A gene expression signature associated with "K-Ras addiction" reveals regulators of EMT and tumor cell survival. (Cancer Cell)
- Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma. (Genes & Development)
- Subtypes of Pancreatic Ductal Adenocarcinoma and Their Differing Responses to Therapy (Nature Medicine)
- Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses (Science)
- Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models. (Cancer Research)
Their papers
- Basics and recent advances in peptide and protein drug delivery (2013) — 683 citations
- Yap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancer (2014) — 668 citations